Using CHADS2, R2CHADS2, CHA2DS2-VASc score for mortality prediction in patients with abnormal low and high ankle-brachial index
© The author(s)..
Abnormal low and high ankle brachial index (ABI) is regarded as peripheral artery disease (PAD) which has extremely high morbidity and mortality. How to identify high-risk PAD patients with increased mortality is very important to improve the outcome. CHADS2, R2CHADS2, and CHA2DS2-VASc score are clinically useful scores to evaluate the annual risk of stroke in patients with atrial fibrillation. However, there was no literature discussing the usefulness of these scores for cardiovascular (CV) and all-cause mortality prediction in the patients with abnormal ABI. This longitudinal study enrolled 195 patients with abnormal low (< 0.9) and high ABI (> 1.3). CHADS2, R2CHADS2, and CHA2DS2-VASc score were calculated for each patient. CV and all-cause mortality data were collected for outcome prediction. The median follow-up to mortality was 90 months. After multivariate analysis, CHADS2, R2CHADS2, and CHA2DS2-VASc score were significant predictors of CV and all-cause mortality (all P < 0.001). CHA2DS2-VASc score had a better additive predictive value than CHADS2 and R2CHADS2 score for CV mortality prediction. R2CHADS2 and CHA2DS2-VASc score had better additive predictive values than CHADS2 score for all-cause mortality prediction. In conclusion, our study is the first study to investigate the usefulness of CHADS2, R2CHADS2, and CHA2DS2-VASc score for mortality prediction in patients with abnormal ABI. Our study showed all three scores are significant predictors for CV and all-cause mortality although there are some differences between the scores. Therefore, using the three scoring systems may help physicians to identify the high-risk PAD patients with increased mortality.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
|---|---|
| Enthalten in: |
International journal of medical sciences - 18(2021), 1 vom: 10., Seite 276-283 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chi, Nai-Yu [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
All-cause mortality |
|---|
| Anmerkungen: |
Date Completed 06.09.2021 Date Revised 06.09.2021 published: Electronic-eCollection Citation Status MEDLINE |
|---|
| doi: |
10.7150/ijms.49018 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM319547949 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM319547949 | ||
| 003 | DE-627 | ||
| 005 | 20231225171703.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.7150/ijms.49018 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1065.xml |
| 035 | |a (DE-627)NLM319547949 | ||
| 035 | |a (NLM)33390796 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Chi, Nai-Yu |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Using CHADS2, R2CHADS2, CHA2DS2-VASc score for mortality prediction in patients with abnormal low and high ankle-brachial index |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 06.09.2021 | ||
| 500 | |a Date Revised 06.09.2021 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © The author(s). | ||
| 520 | |a Abnormal low and high ankle brachial index (ABI) is regarded as peripheral artery disease (PAD) which has extremely high morbidity and mortality. How to identify high-risk PAD patients with increased mortality is very important to improve the outcome. CHADS2, R2CHADS2, and CHA2DS2-VASc score are clinically useful scores to evaluate the annual risk of stroke in patients with atrial fibrillation. However, there was no literature discussing the usefulness of these scores for cardiovascular (CV) and all-cause mortality prediction in the patients with abnormal ABI. This longitudinal study enrolled 195 patients with abnormal low (< 0.9) and high ABI (> 1.3). CHADS2, R2CHADS2, and CHA2DS2-VASc score were calculated for each patient. CV and all-cause mortality data were collected for outcome prediction. The median follow-up to mortality was 90 months. After multivariate analysis, CHADS2, R2CHADS2, and CHA2DS2-VASc score were significant predictors of CV and all-cause mortality (all P < 0.001). CHA2DS2-VASc score had a better additive predictive value than CHADS2 and R2CHADS2 score for CV mortality prediction. R2CHADS2 and CHA2DS2-VASc score had better additive predictive values than CHADS2 score for all-cause mortality prediction. In conclusion, our study is the first study to investigate the usefulness of CHADS2, R2CHADS2, and CHA2DS2-VASc score for mortality prediction in patients with abnormal ABI. Our study showed all three scores are significant predictors for CV and all-cause mortality although there are some differences between the scores. Therefore, using the three scoring systems may help physicians to identify the high-risk PAD patients with increased mortality | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Observational Study | |
| 650 | 4 | |a CHA2DS2-VASc score | |
| 650 | 4 | |a CHADS2 score | |
| 650 | 4 | |a R2CHADS2 score | |
| 650 | 4 | |a all-cause mortality | |
| 650 | 4 | |a cardiovascular mortality | |
| 650 | 4 | |a chronic kidney disease | |
| 700 | 1 | |a Su, Ho-Ming |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Wen-Hsien |e verfasserin |4 aut | |
| 700 | 1 | |a Tsai, Wei-Chung |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Ying-Chih |e verfasserin |4 aut | |
| 700 | 1 | |a Lin, Tzu-Chieh |e verfasserin |4 aut | |
| 700 | 1 | |a Lu, Ye-Hsu |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Chee-Siong |e verfasserin |4 aut | |
| 700 | 1 | |a Lin, Tsung-Hsien |e verfasserin |4 aut | |
| 700 | 1 | |a Lai, Wen-Ter |e verfasserin |4 aut | |
| 700 | 1 | |a Sheu, Sheng-Hsiung |e verfasserin |4 aut | |
| 700 | 1 | |a Hsu, Po-Chao |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of medical sciences |d 2004 |g 18(2021), 1 vom: 10., Seite 276-283 |w (DE-627)NLM155551531 |x 1449-1907 |7 nnns |
| 773 | 1 | 8 | |g volume:18 |g year:2021 |g number:1 |g day:10 |g pages:276-283 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.7150/ijms.49018 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 18 |j 2021 |e 1 |b 10 |h 276-283 | ||